Friday, 25 Sep 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Clinical trial results
Finance
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Fineline Cube
Follow:
14484
Articles
Company
Drug
Kexing GB10 nAMD Injection Secures NMPA Clinical Trial Approval
December 9, 2025
Company
Drug
Ignis Therapeutics Cenobamate NMPA Approval Targets Epilepsy
December 9, 2025
Company
Drug
Ignis Therapeutics Solriamfetol NMPA Approval Targets OSA Sleepiness
December 9, 2025
Company
Drug
Abbisko ABSK043 NSCLC Combo Shows 71% Disease Control at ESMO Asia
December 8, 2025
Company
Drug
Leads Biolabs LBL-034 Multiple-Myeloma ASH Data Shows 82% ORR
December 8, 2025
Company
Drug
Junshi Biosciences roconkibart psoriasis NMPA Acceptance
December 8, 2025
Company
Drug
CSPC SYH2069 GLP-1/GIP Dual Agonist Wins FDA Nod for Obesity
December 8, 2025
Company
Drug
Asieris APL-1401 Ulcerative-Colitis Phase 1b Data Positive
December 8, 2025
Company
Medical Device
Balance Medical ePTFE Pericardial-Membrane Gets NMPA Nod, Ends Import Reliance
December 8, 2025
Company
Deals
Shanghai Pharma X842 Deal Termination with Sinorda
December 8, 2025
Company
Drug
Weixikang Lidocaine-Tetracaine Cream NMPA Clinical Trial Approval
December 8, 2025
Company
Drug
Anke-Biotech PA3-17 CAR-T Pediatric Indication NMPA Accepted
December 8, 2025
1
2
…
215
216
217
218
219
…
1,206
1,207
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?